Advice Fit for a President

At the first meeting of the newly assembled President's Council on Bioethics (PCB), Jan. 17-18, members began their consideration of sensitive bioethical issues not with an analysis of the writings of a scientist, nor a bioethicist, nor a legislator, but a novelist. The group discussed Nathaniel Hawthorne's short story The Birthmark, a literary exploration of mankind's apparent aspiration to root out his own imperfections. The story's protagonist, an alchemist named Aylmer, convinces his wife Ge

Written byEugene Russo
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

The story's protagonist, an alchemist named Aylmer, convinces his wife Georgiana that he can safely remove a hand-shaped birthmark from her cheek, the lone blemish of an otherwise perfect physical specimen. Tragically, Aylmer removes the birthmark but unintentionally kills Georgiana in the process. Writes Hawthorne, "the fatal hand had grappled with the mystery of life, and was the bond by which an angelic spirit kept itself in union with a mortal frame."

Hawthorne's tale, says PCB chairman Leon Kass, is a commentary on the implications of "trying to eliminate all signs of our mortality and finitude." According to Kass, who is on leave from the University of Chicago's Committee for Social Thought, the discussion was part of an effort to "develop the terms of a richer and deeper bioethics that does full justice to the issues." This is just one of several difficult assignments that the new panel, with its ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies